A global pharmaceutical company headquartered in the U.S. reached out to BWD shortly after establishing its new ESG & Sustainability team. The new team needed guidance on best practice strategy and governance frameworks for focusing its efforts and enhancing the rigor of its oversight.
We developed strategic workplans with measurable milestones about where the new team needed to actively drive the agenda (such as setting emissions reduction targets), where its input could support an existing agenda (such as formalizing community contribution protocols), and where its support was needed ad hoc (such as public policy engagement).
Our collaboration helped the new function integrate into the organization by identifying where it could have the most valuable impact. The board and executive congratulated the new team on the improved strategy, which also contributed to a stronger ESG Report featuring measurable targets and enhanced alignment with reporting frameworks.